1 / 16

V. Petrenkiene, D. Petrauskas L. Kupcinskas, Lithuanian University of Health sciences Clinic of Gastroenterology Kauna

Over the past decade many studies have evaluated non-invasive tests of liver fibrosis to assess the presence and severity of fibrosis in chronic liver diseases. Non-invasive markers and commercial tests of liver fibrosis have been proposed and assessed in the clinical setting as surrogates of

heavynne
Download Presentation

V. Petrenkiene, D. Petrauskas L. Kupcinskas, Lithuanian University of Health sciences Clinic of Gastroenterology Kauna

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. V. Petrenkiene*, D. Petrauskas L. Kupcinskas, Lithuanian University of Health sciences Clinic of Gastroenterology Kaunas

    3. AIM

    4. METHODS (1)

    5. Biopsy: Menghini 14-gauge needle; Histology: Knodell–Ishak fibrosis staging system on a scale F0-F6 (Masson trichrome stain).

    6. METHODS (3)

    7. METHODS (4)

    8. RESULTS (1) 323 naive CHC patients 194 (60.1%) male 129 (39.9%) female Mean age: 48.5 year Histological staging F0 6.5% (n= 21) F1 13.9% (n= 45) F2 25.4% (n= 82) F3 23.5% (n= 76) F4 9.9% (n= 32) F5 3.7% (n= 12) F6 17.0% (n= 55)

    9. METHODS (5)

    10. Results (2)

    11. RESULTS (3)

    12. RESULTS (4)

    14. CONCLUSIONS (1)

    15. CONCLUSIONS (2)

More Related